Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia

Meropenem monotherapy vs ceftazidime plus amikacin have been approved for use against febrile neutropenia. To assess the effectiveness and safety of them for empirical treatment of cancer patients with febrile neutropenia, we conducted a meta-analysis of randomized controlled trial. Randomized contr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2021-02, Vol.100 (8), p.e24883-e24883
Hauptverfasser:	Wang, Ying, Du, Zhichao, Chen, Yongdong, Liu, Yugang, Yang, Zhitang
Format:	Artikel
Sprache:	eng
Schlagworte:	Amikacin - administration & dosage Amikacin - adverse effects Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Ceftazidime - administration & dosage Ceftazidime - adverse effects Drug Therapy, Combination Febrile Neutropenia - drug therapy Humans Meropenem - administration & dosage Meropenem - adverse effects Neoplasms - drug therapy Systematic Review and Meta-Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!